The Indianapolis-based drugmaker said the supercomputer will power an "AI factory" designed to accelerate drug discovery and development.
NPPA allowed discontinuation of 21 scheduled formulations in FY25: Gireesh Babu, New Delhi Wednesday, October 29, 2025, 08:00 ...
Shares falls as traders abandon rate bets after core CPI tops forecasts; Nick Scali sees strong sales; Woolworths sales miss; ...
The London Company reviews Q3 Mid Cap results, citing quality headwinds and top stock drivers like SGI and NEU. See how their ...
The London Company reviews Q3 Mid Cap strategy vs. Russell Midcap, spotlighting long-term outperformance. See how disciplined ...
Life sciences group Thermo Fisher is nearing an all-cash takeover of drug trial software maker Clario in a deal that could ...
TipRanks on MSN
BioMarin’s Earnings Call: Growth Amid Challenges
Biomarin Pharmaceutical Inc. (($BMRN)) has held its Q3 earnings call. Read on for the main highlights of the call. BioMarin Pharmaceutical Inc.’s ...
Local educators say Hispanic students and parents are afraid to leave their homes and risk detainment by the new Memphis Safe Task Force. Some want the district to offer more support.
Vanigent BioPharm has launched Vanitrack, an AI-powered platform that combines compliance and expense management for ...
Phinge® Corporation, creator of the upcoming Netverse® hardware-verified technology platform, today detailed a proposal for federal agencies to dramatically reduce waste, fraud, and abuse (WFA) in ...
Eli Lilly partners with Nvidia to build the pharma industry’s most powerful AI supercomputer, aiming to speed up drug discovery and innovation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback